ReviewHeliyon2025
Collaborative arts therapies as a supportive intervention for autism spectrum disorders: Bibliometric analysis, insights, and directions.
Review in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Design and development of an endoscopic robotic system and deep reinforcement learning path planning algorithm for fine-needle biopsy of liver lesions.International journal of computer assisted radiology and surgery · 2026Article
- Berberine and its structural diversity: structure-activity relationships, molecular mechanisms, and drug discovery opportunities.Molecular biology reports · 2026Review
- An intensity-aware vision transformer framework for precise localization of vitreous hemorrhage in fundus imaging.International ophthalmology · 2026Article
- A DeepSeek cross-modal platform for personalized art education in Autism Spectrum Disorder.Scientific reports · 2025Article
- Nanotechnology in placental cancers: advances in targeted therapy and non-invasive diagnostics.Medical oncology (Northwood, London, England) · 2025Review
- Plant-derived triterpenoid saponins: multifaceted roles and bioengineering prospects.Plant cell reports · 2025Review
- Perfluorooctane sulfonic acid: a possible risk factor of endothelial dysfunction based on in silico and in vitro studies.Archives of toxicology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Arts therapies (ATs) for the treatment of autism spectrum disorders (ASD) has attracted widespread attention from scholars. However, resources, technical, and ethical issues still pose significant obstacles to current research. A collaborative design approach is needed to guide the intervention treatment process involving multiple stakeholders. Therefore, this study focuses on exploring the current status, development and potential value of the collaborative arts therapies (CATs), providing a comprehensive perspective for subsequent research. Methods: The Web of Science, PubMed, ScienceDirect, and Cochrane Library were searched for publications up to August 30, 2023, related to the use of CATs for the treatment of ASD. CiteSpace was used to build a knowledge graph to achieve visual analysis of current research countries, institutions, journals, authors, and hot topics. Results: A total of 845 articles met the inclusion criteria. In terms of quantity, the USA is the leading country which has the greatest influence in advancing the field. The University of Haifa is the most productive institution. Conclusions: Research on CATs as an adjunctive therapy for the treatment of ASD is evolving. Providing comprehensive rehabilitation and support intervention for patients with ASD is a key research direction. The research process requires more interdisciplinary resources and technical assistance. Collaboration will be the best way to improve the effectiveness of ATs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.